Additional antihypertensive effect of magnesium supplementation with an angiotensin II receptor blocker in hypomagnesemic rats

다국어 초록 (Multilingual Abstract)

Background/Aims: Magnesium (Mg) is an essential element for vascular function and blood pressure regulation. Several studies have demonstrated that Mg concentration is inversely associated with blood pressure, and that Mg supplementation attenuates hypertension. The purpose of this study was to evaluate the effect of dietary Mg supplementation on the blood pressure effects of an angiotensin II receptor blocker (ARB) in hypomagnesemic rats.
Methods: Fifty male Sprague-Dawley rats were randomly divided into Mg-deficient (n = 30), normal diet plus Mg (n = 10), and control groups (n = 10). Mg-free, high-Mg, and normal-Mg diets were respectively fed to the rats. After 14 weeks, 10 of the 30 Mg-deficient rats were treated with Mg, 10 Mg-deficient rats received an ARB, and 10 Mg-deficient rats received an ARB plus Mg for 4 weeks.
Results: Systolic blood pressure was significantly higher in the Mg-deficient rats than in the control rats at week 14. Hypomagnesemic rats exhibited decreased systolic blood pressure after treatment with Mg, and systolic blood pressure showed a greater decrease after ARB treatment. Treatment with the ARB/Mg combination resulted in the greatest decrease in systolic blood pressure. Mg deficiency did not affect the serum angiotensin II level, but did increase the serum aldosterone concentration. Concomitant Mg/ARB supplementation significantly decreased the elevated serum aldosterone level in hypomagnesemic rats. Kidney tissues of the hypomagnesemic rats revealed mild to moderate inflammatory infiltrates. Mg and/or ARB treatment did not reverse the inflammatory reaction in the kidneys of hypomagnesemic rats.
Conclusions: Concurrent dietary Mg supplementation can enhance ARB-induced blood pressure reduction in rats with hypomagnesemic hypertension.

참고문헌 (Reference)

1 박문향, "신생검 조직검사 진단양식의 실용 지침" 대한병리학회 44 (44): 613-622, 2010

2 Touyz RM, "Transient receptor potential melastatin 6 and 7 channels, magnesium transport, and vascular biology: implications in hypertension" 294 : 1103-1118, 2008

3 Laurant P, "Timecourse of the change in blood pressure level in magnesium- deficient Wistar rats" 82 : 243-251, 1999

4 Moncada S, "The role of prostacyclin in vascular tissue" 38 : 66-71, 1979

5 Guerrero-Romero F, "The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial" 23 : 245-251, 2009

6 Widman L, "The dose-dependent reduction in blood pressure through administration of magnesium: a double blind placebo controlled cross-over study" 6 : 41-45, 1993

7 Resnick LM, "Serum ionized magnesium: relation to blood pressure and racial factors" 10 (10): 1420-1424, 1997

8 Touyz RM., "Role of magnesium in the pathogenesis of hypertension" 24 : 107-136, 2003

9 Sontia B, "Role of magnesium in hypertension" 458 : 33-39, 2007

10 Kesteloot H, "Relationship of dietary sodium, potassium, calcium, and magnesium with blood pressure: Belgian Interuniversity Research on Nutrition and Health" 12 : 594-599, 1988

11 Laurant P, "Physiological and pathophysiological role of magnesium in the cardiovascular system: implications in hypertension" 18 : 1177-1191, 2000

12 Shechter M, "Oral magnesium therapy improves endothelial function in patients with coronary artery disease" 102 : 2353-2358, 2000

13 Hatzistavri LS, "Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension" 22 : 1070-1075, 2009

14 Barbagallo M, "Oral magnesium supplementation improves vascular function in elderly diabetic patients" 23 : 131-137, 2010

15 Kisters K., "Oral magnesium supplementation improves borderline hypertension" 24 : 17-, 2011

16 Altura BM, "Noise-induced hypertension and magnesium in rats: relationship to microcirculation and calcium" 72 : 194-202, 1992

17 Fox C, "Magnesium: its proven and potential clinical significance" 91 : 1195-1201, 2001

18 Weglicki WB, "Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin" 110 : 169-173, 1992

19 Saito N, "Magnesium, calcium and trace elements in spontaneously hypertensive rats" 22 : 212-214, 1995

20 Rosanoff A, "Magnesium supplements may enhance the effect of antihypertensive medications in stage 1 hypertensive subjects" 23 : 27-40, 2010

21 Touyz RM, "Magnesium supplementation attenuates, but does not prevent, development of hypertension in spontaneously hypertensive rats" 12 (12): 757-765, 1999

22 Touyz RM., "Magnesium supplementation as an adjuvant to synthetic calcium channel antagonists in the treatment of hypertension" 36 : 140-141, 1991

23 Berthon N, "Magnesium supplementation and deoxycorticosterone acetate: salt hypertension: effect on arterial mechanical properties and on activity of endothelin-1" 80 : 553-561, 2002

24 Swaminathan R., "Magnesium metabolism and its disorders" 24 : 47-66, 2003

25 Nadler JL, "Magnesium deficiency produces insulin resistance and increased thromboxane synthesis" 21 (21): 1024-1029, 1993

26 Altura BM, "Magnesium and cardiovascular biology: an important link between cardiovascular risk factors and atherogenesis" 41 : 347-359, 1995

27 Blache D, "Long-term moderate magnesium-deficient diet shows relationships between blood pressure, inflammation and oxidant stress defense in aging rats" 41 : 277-284, 2006

28 Ferrara LA, "Long-term magnesium supplementation in essential hypertension" 81 : 25-33, 1992

29 Cappuccio FP, "Lack of effect of oral magnesium on high blood pressure: a double blind study" 291 : 235-238, 1985

30 Laurant P, "Inf luence of endothelium on Mg(2+)-induced relaxation in noradrenaline-contracted aorta from DOCA-salt hypertensive rat" 258 : 167-172, 1994

31 Iseri LT, "French JH. Magnesium: nature’s physiologic calcium blocker" 108 : 188-193, 1984

32 Kawano Y, "Effects of magnesium supplementation in hypertensive patients: assessment by office, home, and ambulatory blood pressures" 32 : 260-265, 1998

33 Sanjuliani AF, "Effects of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients" 56 : 177-183, 1996

34 Touyz RM, "Effects of low dietary magnesium intake on development of hypertension in stroke-prone spontaneously hypertensive rats: role of reactive oxygen species" 20 : 2221-2232, 2002

35 Yanahira S, "Effects of lactitol-oligosaccharides on calcium and magnesium absorption in rats" 43 : 123-132, 1997

36 Berthelot A, "Effects of dietary magnesium on the development of hypertension in the spontaneously hypertensive rat" 2 : 343-353, 1983

37 Laurant P, "Effect of magnesium deficiency on blood pressure and mechanical properties of rat carotid artery" 33 : 1105-1110, 1999

38 Laurant P, "Dietary magnesium supplementation modif ies blood pressure and cardiovascular function in mineralocorticoid-salt hypertensive rats but not in normotensive rats" 125 : 830-841, 1995

39 Evans GH, "Dietary magnesium does not affect blood pressure in spontaneously hypertensive rats" 11 : 619-632, 1989

40 Makynen H, "Dietary calcium and magnesium supplements in spontaneously hypertensive rats and isolated arterial reactivity" 115 : 1455-1462, 1995

41 Kisters K, "Decreased membrane Mg2+ concentrations in a subgroup of hypertensives: membrane model for the pathogenesis of primary hypertension" 11 (11): 1390-1393, 1998

42 Lind L, "Blood pressure response during long-term treatment with magnesium is dependent on magnesium status: a double-blind, placebo-controlled study in essential hypertension and in subjects with high-normal blood pressure" 4 : 674-679, 1991

43 Touyz RM, "Angiotensin II type I receptor modulates intracellular free Mg2+ in renally derived cells via Na+-dependent Ca2+-independent mechanisms" 276 : 13657-13663, 2001

44 Ginn HE, "Aldosterone secretion in magnesium-deficient rats" 80 : 969-971, 1967

45 Briel RC, "Action of magnesium sulfate on platelet prostacyclin interaction and prostacyclin of blood vessels" 153 : 232-, 1985

46 Yanagisawa M, "A novel potent vasoconstrictor peptide produced by vascular endothelial cells" 332 : 411-415, 1988

47 Adrian M, "A long-term moderate magnesium-deficient diet aggravates cardiovascular risks associated with aging and increases mortality in rats" 26 : 44-52, 2008

48 Ameen M, "A comparison of free intracellular calcium and magnesium levels in the vascular smooth muscle and striated muscle cells of the spontaneously hypertensive and Wistar Kyoto normotensive rat" 639 : 550-553, 1991